Nama's AI scorecard currently rates BrightSpring Health Services Hold (5.6 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.

What is BTSG's P/E ratio?

BrightSpring Health Services trades at a trailing price-to-earnings ratio of 39.3.

When does BTSG report earnings?

BrightSpring Health Services's next scheduled report is on Feb 26, 2027. Analysts expect EPS of $0.54.

What is the BTSG price target?

The median analyst price target from 17 analysts is $84.00, with a range of $73.50 – $92.00.

Is BTSG Shariah compliant?

Nama's AAOIFI-style screen reads BrightSpring Health Services as Not Shariah Compliant. At least one of the three ratios or the industry test failed.

Nama Insights

BrightSpring Health Services (BTSG)

Healthcare · Health Information Services · NASDAQ

BrightSpring Health Services (BTSG) is a Healthcare company in the Health Information Services industry. It has a market capitalization of $13.36B, a trailing price-to-earnings ratio of 39.3 and a free-cash-flow yield of 2.7%. Over the most recent reported fiscal year, revenue grew 28.2%. Nama's AI scorecard rates it Hold, 5.6 out of 10. On 12-month momentum it ranks in the leading band of its market.

AI scorecard

Hold · 5.6/10

The sections balance. As of Nov 7, 2026.

Momentum

Leading · +95.7% over 12 months ex. last

Top 20% of its market on the past year's steady rise.

Shariah screen

Not Shariah Compliant

At least one of the three ratios or the industry test failed.

Off its high

-8.9%

How far the last close sits under the highest price of the past five years.

Market cap	$13.36B
Trailing P/E	39.3
Price / book	6.5
Price / sales	0.9
FCF yield	2.7%
Dividend yield	—
Gross margin	12.4%
Operating margin	3.1%
Net margin	2.5%
Revenue growth (YoY)	+28.2%
Revenue growth (3-yr annual)	+18.7%
EPS growth (YoY)	+89.1%
FCF/share growth (YoY)	—
Beta	1.9
Exchange	NASDAQ
Sector	Healthcare
Industry	Health Information Services

BTSG earnings

Next report: Feb 26, 2027 (Q4 2026, EPS estimate $0.54). Beat the EPS estimate in 3 of 4 recent quarters.

Quarter	Reported	EPS	Estimate	Surprise	Revenue
Q3 2026	Oct 30, 2026	$0.54	$0.47	+14.9%	$4.21B
Q2 2026	Jul 31, 2026	$0.45	$0.40	+12.5%	$3.87B
Q1 2026	May 1, 2026	$0.39	$0.31	+25.8%	$3.61B
Q4 2025	Feb 27, 2026	$0.33	$0.35	-5.7%	$3.55B

BTSG analyst price target

Median target $84.00 from 17 analysts, ranging $73.50 – $92.00.

Health Information Services peers

Ticker	Company	Market cap	P/E
VEEV	Veeva Systems	$49.18B	35.0
TEM	Tempus AI	$13.87B	—
HNGE	Hinge Health	$9.34B	51.7
HQY	HealthEquity	$8.57B	23.3
TXG	10x Genomics	$7.72B	296.4
DOCS	Doximity	$5.79B	23.7
WAY	Waystar	$5.45B	17.2
HTFL	Heartflow	$4.56B	—

Explore live BTSG data on Nama Insights →

BTSG FAQ

Is BTSG a buy?: Nama's AI scorecard currently rates BrightSpring Health Services Hold (5.6 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is BTSG's P/E ratio?: BrightSpring Health Services trades at a trailing price-to-earnings ratio of 39.3.
When does BTSG report earnings?: BrightSpring Health Services's next scheduled report is on Feb 26, 2027. Analysts expect EPS of $0.54.
What is the BTSG price target?: The median analyst price target from 17 analysts is $84.00, with a range of $73.50 – $92.00.
Is BTSG Shariah compliant?: Nama's AAOIFI-style screen reads BrightSpring Health Services as Not Shariah Compliant. At least one of the three ratios or the industry test failed.